NCT07117162 · RECRUITING
Improving Access to Care for Veterans With Memory Loss
This trial tests a new way of delivering care to Veterans with mild memory loss or early dementia at VA Pittsburgh. It combines telehealth, advanced diagnostics, and streamlined workflows. The goal is to speed up screening for amyloid-targeting therapies. It is a care-delivery study, not a drug test, so no phase applies.
You may qualify if
- Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score >7
- Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD
- Enrolled in VA care
- Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
- Has a working telephone
- 18 years and older
- Able to communicate in English
- Willing to give informed consent.
You're excluded if
- None
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-07-17